Guru Ownership Trend
Guru Analysis for BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (BMRN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.01 B.
Top institutional holders include Cliff Asness and Andreas Halvorsen.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $105.19 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 173.3%. Conversely, Joel Greenblatt reduced exposure by 35.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for BioMarin Pharmaceutical Inc. (BMRN)
Major holders include Cliff Asness ($429.35 M), Andreas Halvorsen ($398.94 M), Steven Cohen ($67.74 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 17.86 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $105.19 M, with 5 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 3 fully exited BMRN. The total reported sell value was $51.1 M.
Yes, 0 managers opened new positions in BMRN, and 5 increased their existing holdings. The total reported buy value was $156.29 M.
